Active Surveillance for Adverse Events After Immunization With IXIARO(R) Among U.S. Military Service Personnel.
Phase of Trial: Phase IV
Latest Information Update: 12 Mar 2015
At a glance
- Drugs IC 51 (Primary)
- Indications Japanese encephalitis
- Focus Adverse reactions
- Sponsors Valneva
- 09 Mar 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 25 Nov 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.
- 19 Apr 2011 New trial record